Entering text into the input field will update the search result below

FDA OKs BioMarin's cerliponase alfa for type of Batten disease; shares ahead 1%

Recommended For You

About BMRN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BMRN--
BioMarin Pharmaceutical Inc.